Antithyroid Therapy Improves Glycemic Control in Hyperthyroid Type 1 Diabetes Mellitus Patients

Open access


Background and aims. Thyroid disorders are more frequently met in patients with diabetes mellitus than in general population. Thyroid hormones increase glycemia by several mechanisms, but the effect of antithyroid treatment on glucose control in type 1 diabetes mellitus (T1DM) cases is not well studied. The aim of our work was to analyze the evolution of glycemic control of T1DM patients submitted to specific therapy when hyperthyroidism was diagnosed. Material and method. The study group comprised by 37 patients, 35 women (94.6%) and 2 men (5.4%), known as having T1DM and diagnosed with hyperthyroidism during a 10-years interval. They were treated with antithyroid medication and reassessed after 6 months regarding thyroid function and glycemic control. Results. In the whole group, there was a significant decrease in mean HbA1c level (with 0.41%) and a significant increase in the percentage of patients being in the glycemic target (from 10.8% to 35.1%). The better glycemic control was obtained with a lower mean insulin dose. Patients who became euthyroid had a better evolution regarding glucose control in comparison to those who remained hyperthyroid. Changes in other cardiovascular risk factors were noted: systolic blood pressure decreased; diastolic blood pressure, HDL cholesterol, LDL cholesterol, non-HDL cholesterol, triglycerides and body weight increased. TSH and HbA1c values were inversely correlated. Conclusions. The therapeutic control of excessive thyroid function significantly contributes to the improvement of glycemic control in patients with T1DM and induces changes in the cardiovascular risk factors profile.

1. Tunbridge WM, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7: 481-493, 1977

2. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 160: 526-534, 2000

3. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489-499, 2002

4. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 12: 622-627, 1995

5. Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Diabet Med 15: 148-150, 1998

6. Barker JM. Clinical review: Type 1 diabetesassociated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 91: 1210-1217, 2006

7. Mouradian M, Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care 6: 512-520. 1983

8. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res 2011: 439-463, 2011

9. Brenta G. Diabetes and thyroid disorders. Br J Diabetes Vasc Dis 10: 172-177, 2010

10. Bech K, Damsbo P, Eldrup E et al. β-cell function and glucose and lipid oxidation in Graves’ disease. Clin Endocrinol (Oxf) 44: 59-66, 1996

11. Beer SF, Parr JH, Temple RC, Hales CN. The effect of thyroid disease on proinsulin and C-peptide levels. Clin Endocrinol (Oxf) 30: 379-383, 1989

12. Solá E, Morillas C, Garzón S, Gómez-Balaguer M, Hernández-Mijares A. Association between diabetic ketoacidosis and thyrotoxicosis. Acta Diabetol 39: 235-237, 2002

13. Bhattacharyya A, Wiles PG. Diabetic ketoacidosis precipitated by thyrotoxicosis. Postgrad Med J 75: 291-292, 1999

14. Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J ClinPract 64: 1130-1139, 2010

15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 329: 977-986, 1993

16. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. JAMA 290: 2159-2167, 2003

17. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131): 837-853, 1998

18. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352(9131): 854-865, 1998

19. American Diabetes Association. Standards of medical care in diabetes - 2013. Diabetes Care 36(Suppl 1): S11-S66. 2013

20. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55: 1577-1596, 2012

21. Potenza M, Via MA, Yanagisawa RT. Excess thyroid hormone and carbohydrate metabolism. Endocr Pract 15: 254-262, 2009

22. Cooppan R, Kozak GP. Hyperthyroidism and diabetes mellitus. An analysis of 70 patients. Arch Intern Med 140: 370-373, 1980

23. Zosin I, Vlad M, Crista C, Anghel A. The evaluation of iodine intake by means of ioduria and thyroid volumetry in children from Timisoara. Timisoara Medicala XLI(1-2): 32-37, 1996

24. Vlad M, Tirla MA, Banica D, Milos A, Zosin I. The distribution of thyroid pathology in a region with adequate iodine intake. Acta Endocrinologica (Buc) IX (1, Suppl 1): 9-10, 2013

25. Chin KY, Ima-Nirwana S, Mohamed IN, Aminuddin A, Johari MH, Ngah WZ. The relationships between thyroid hormones and thyroid-stimulating hormone with lipid profile in euthyroid men. Int J Med Sci 11: 349-355, 2014

26. Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol 187: 1-15, 2005

27. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 338: 712-718, 1998

Romanian Journal of Diabetes Nutrition and Metabolic Diseases

The Journal of Romanian Society of Diabetes Nutrition and Metabolic Diseases

Journal Information

CiteScore 2017: 0.11

SCImago Journal Rank (SJR) 2017: 0.122
Source Normalized Impact per Paper (SNIP) 2017: 0.077


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 198 191 13
PDF Downloads 72 71 10